UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (16), p.1735

2016

Volltextzugriff (PDF)

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Gut, 2016-03, Vol.65 (3), p.374-389

2016

Volltextzugriff (PDF)

Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2019-06, Vol.15 (2), p.198

2019

Volltextzugriff (PDF)

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

The New England journal of medicine, 2013-04, Vol.368 (15), p.1379-1387

2013

Volltextzugriff (PDF)

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Journal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221

2015

Volltextzugriff (PDF)

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2011-02, Vol.4 (2), p.191-197

2011

Volltextzugriff (PDF)

Utility of Peak Creatine Kinase-MB Measurements in Predicting Myocardial Infarct Size, Left Ventricular Dysfunction, and Outcome After First Anterior Wall Acute Myocardial Infarction (from the INFUSE-AMI Trial)

The American journal of cardiology, 2015-03, Vol.115 (5), p.563-570

2015

Volltextzugriff (PDF)

Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?

The Lancet (British edition), 2013-08, Vol.382 (9892), p.624-632

2013

Volltextzugriff (PDF)

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy

JACC. Cardiovascular interventions, 2015-10, Vol.8 (12), p.1552-1562

2015

Volltextzugriff (PDF)

Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

The American journal of cardiology, 2015-06, Vol.115 (11), p.1481-1486

2015

Volltextzugriff (PDF)

Outcomes following PCI in CABG candidates during the COVID‐19 pandemic: The prospective multicentre UK‐ReVasc registry

Catheterization and cardiovascular interventions, 2022-02, Vol.99 (2), p.305-313

2022

Volltextzugriff (PDF)

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

European heart journal, 2018-07, Vol.39 (26), p.2484-2493

2018

Volltextzugriff (PDF)

Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial

BMJ open, 2022-05, Vol.12 (5), p.e055878

2022

Volltextzugriff (PDF)

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Endoscopy, 2016-04, Vol.48 (4), p.385

2016

Volltextzugriff (PDF)

Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study)

The American journal of cardiology, 2014-09, Vol.114 (6), p.811-819

2014

Volltextzugriff (PDF)

The value of Guidelines in everyday clinical practice

European heart journal, 2018-04, Vol.39 (13), p.1046-1048

Gershlick, Anthony H

2018

Volltextzugriff (PDF)

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

European heart journal, 2018-01, Vol.39 (2), p.119-177

2018

Volltextzugriff (PDF)

Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

Value in health, 2017-06, Vol.20 (6), p.745-751

2017

Volltextzugriff (PDF)

Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study

Journal of the American Heart Association, 2016-06, Vol.5 (6), p.n/a

2016

Volltextzugriff (PDF)

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.963-972

2015

Volltextzugriff (PDF)

High-risk NSTE-ACS: high time for robust data

European heart journal, 2021-01, Vol.42 (4), p.352-352

2021

Volltextzugriff (PDF)

Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction

Journal of cardiovascular magnetic resonance, 2014-05, Vol.16 (1), p.38-38, Article 38

2014

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(187)
Japanisch
(19)
Spanisch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(122)
Science & Technology
(122)
Humans
(108)
Cardiovascular System & Cardiology
(100)
Cardiac & Cardiovascular Systems
(99)
Male
(60)
Female
(54)
Middle Aged
(44)
Aged
(43)
Treatment Outcome
(39)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Stents
(34)
Heart Attacks
(32)
Percutaneous Coronary Intervention
(32)
Myocardial Infarction
(28)
Coronary Angiography
(23)
Time Factors
(22)
Percutaneous Coronary Intervention - Methods
(21)
Cardiology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club

Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

Utility of Peak Creatine Kinase-MB Measurements in Predicting Myocardial Infarct Size, Left Ventricular Dysfunction, and Outcome After First Anterior Wall Acute Myocardial Infarction (from the INFUSE-AMI Trial)

Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy

Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

Outcomes following PCI in CABG candidates during the COVID‐19 pandemic: The prospective multicentre UK‐ReVasc registry

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

Very early invasive angiography versus standard of care in higher-risk non-ST elevation myocardial infarction: study protocol for the prospective multicentre randomised controlled RAPID N-STEMI trial

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study)

The value of Guidelines in everyday clinical practice

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)

Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial

Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)

High-risk NSTE-ACS: high time for robust data

Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction

Suchergebnisse filtern